Poseida Therapeutics, Inc. (PSTX) Financials
PSTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 273.9 million | 170.2 million |
2023-09-30 | 302.3 million | 178.6 million |
2023-06-30 | 281.2 million | 145.9 million |
2023-03-31 | 313.6 million | 156.1 million |
PSTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -29.1 million | 5.1 million |
2023-09-30 | 7.1 million | 5.1 million |
2023-06-30 | -34.5 million | 5.5 million |
2023-03-31 | -38.8 million | 7.5 million |
PSTX Net Income
No data available :(
PSTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 212.2 million | - | 26.8 million |
2023-09-30 | 238.8 million | - | 27.8 million |
2023-06-30 | 214.6 million | 58.4 million | 28.7 million |
2023-03-31 | 247.2 million | 58.3 million | 29.6 million |
PSTX Shares Outstanding
PSTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 309000 | 42.0 million | 8.9 million | - |
2023-09-30 | 789000 | 37.5 million | 8.1 million | - |
2023-06-30 | 1.2 million | 39.2 million | 8.7 million | - |
2023-03-31 | 784000 | 38.1 million | 11.8 million | - |
PSTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 25.0 million | 4.2 million |
2023-09-30 | 9.4 million | 1.4 million |
2023-06-30 | 20.0 million | 1.4 million |
2023-03-31 | 10.3 million | 1.3 million |
PSTX
Price: $2.79
52 week price:
Earnings Per Share: -1.37 USD
P/E Ratio: -2.27
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 268000
Market Capitalization: 262.4 million